Beverly Oncology Acquires LinaTech's 106 Leaf DMLC and Treatment Planning Software for Advanced Radiotherapy Treatments

Feb 2, 2012

In a bid to deliver advanced radiotherapy treatments and improve treatment delivery times while reducing operational costs, Beverly Oncology has acquired LinaTech's 106 Leaf DMLC and TPS. The purchase will allow Beverly Oncology, a leading cancer clinic, to offer cutting-edge RT treatments to its patients.

With the acquisition of the DMLC and TPS, Beverly Oncology is poised to serve an increasing number of patients each year. The DMLC will also enable the clinic to do away with using compensators, which are time-consuming to set up, costly, and not environmentally friendly. LinaTech was able to provide Beverly Oncology with a cost-effective upgrade solution, saving the clinic millions compared to similar solutions from other vendors.

By acquiring LinaTech's 106 Leaf DMLC and TPS, Beverly Oncology is well-positioned to deliver advanced radiotherapy treatments while improving treatment delivery times and reducing operational costs. With this new technology, Beverly Oncology is poised to remain a leading cancer clinic, offering the best possible care to its patients.

To learn more, please contact us.